Both products can be used in the UK to provide protection against RSV disease in certain settings. Abrysvo was cleared for ...

Venglustat is designed to reduce the toxic build-up, and the new trial showed that a daily dose of the drug achieved ...

Joenja is a sizeable contributor to Pharming's revenues, accounting for €38 million ($45 million) of its total sales of €70 ...

The FDA has started accepting requests to participate in its PreCheck pilot programme, designed to make it easier and quicker ...

Patients in the EU with rare disease thymidine kinase 2 deficiency (TK2d) could be just weeks away from having the first ...

Eli Lilly has revealed the fourth new manufacturing site in its $27 billion capital investment spree in the US – a $3.5 ...

As this complexity deepens, a simple truth emerges: classical measurement frameworks cannot keep pace with a system that is no longer linear, nor even merely non-linear, but fundamentally ...

The UK has lost its measles elimination status, according to the World Health Organization (WHO), after recording 2,911 laboratory-confirmed measles cases in England in 2024 – the highest number in a ...

Summit Therapeutics has moved ahead in the race to bring a therapy targeting both VEGF and PD-(L)1 to market, after the FDA started a review of its ivonescimab drug for lung cancer. The US regulator ...

At the JP Morgan Healthcare conference this year, a lot of the discourse around AI drug discovery focused on making the leap from purely in silico drug discovery operations to real-world operations ...

The Pfizer Foundation recently announced a new three-year, $10 million investment through its Action & Impact: A Cancer Care ...